Users Coming Off Slimming Injections Gain Back Weight at a Quadrupled Rate Than Dieters

Fresh analysis suggests that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who end conventional lifestyle programs.

Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"People purchasing such treatments need to be aware of the danger of fast weight regain when the medication ends," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a return to original weight within about one and a half years.

Analyzing Approaches

The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the results of the injectable medications with older methods.

Scientists point out that people who shed pounds through lifestyle changes alone generally have a more gradual weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Quick Regain

Doctors suggest the way of the drugs accounts for the heightened rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates feelings of fullness.

"Sustained high doses of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this medication leads to appetite is unsuppressed, making excessive eating a significant risk."

A Lifelong Disease?

Health authorities advise the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Many experts argue that, due to the high risk of relapse, the treatment should be considered long-term.

This view is reinforced by drug manufacturers, who say that the findings "highlight the chronic character of excess weight," comparing it to managing diseases like hypertension.

Patient Testimonies

Individuals who have stopped the medication describe a intense resurgence of cravings.

"I experienced a trigger that goes on and you become starving," described an individual.

This challenge is compounded if individuals have not developed sustainable lifestyle or habit modifications during treatment.

Widespread Adoption

Survey data indicate that millions of people in the UK have used these injections in the past year, with demand remaining high.

• Use is higher among females compared to males.
• The middle-aged demographic shows the highest usage rates.
• Many access the drugs through private prescriptions rather than the NHS.

Ultimately, experts caution that while the jabs are effective tools for shedding pounds, they are not a permanent solution and long-term success likely depends on integrated behavioural changes.